Marico Ltd. share price target

*over or under performance to benchmark index Consolidated revenue grew 26.6% YoY to Rs. 3,537cr, driven by robust domestic markets, with Bangladesh leading the way with 29% growth, followed by Vietnam at...

Marico Limited is one of India's leading fast-moving consumer goods (FMCG) companies with a strong presence in the beauty and wellness, edible oils, and healthy foods segments. Founded in 1990 and headquartered in Mumbai, the company has built a strong portfolio of well recognized consumer brands across hair care, cooking oils, and nutrition products. Its flagship brands include Parachute coconut oil, Saffola edible oils and healthy foods, and Hair & Care hair oils, which collectively command strong market leadership in their respective categories. Over the years, Marico has also diversified into new-age consumer segments through digital-first brands such as Beardo in male grooming and Plix in plant-based nutrition. The company operates in more than 25 countries across Asia and Africa, with key international markets including Bangladesh, Vietnam, South Africa, and the Middle East region. Marico's business model is focused on building strong consumer brands, expanding distribution across rural and urban markets and leveraging premiumization and innovation...

Transforming into a digital first play; To double revenues by FY28: Marico is transforming itself into a digital first consumer business from conventional FMCG through inorganic route focusing on expanding in foods and premium personal care categories. It endeavours to double its revenues by FY30 (growing at CAGR of 15%) with core growing at CAGR of 10-12% and new businesses growing at CAGR of 20% over FY25-30. In foods the company is focusing on sub-categories such as premium snacking, health & wellness and modern breakfast. It has recently acquired...

Decent Q3; Input cost inflation phasing out Q3FY26 performance: India business grew by 24% YoY driven by mix of volume and price led growth. Volume growth stood at 8% YoY continuing its high single digit volume growth for 3rd consecutive quarter. International business grew by 21% YoY on constant currency basis. Inflated copra prices (+84% YoY) led to 596bps YoY decline in gross margins to 43.5%. EBIDTA margins declined by 217bps...

...

Strong Q2; Margin to expand by 200bps in FY27 Q2FY26 performance: India business grew by 35% YoY driven by mix of volume and price led growth. Volume growth stood at 7% YoY continuing its positive growth trajectory for 10th consecutive quarter. International business grew by 20% YoY on constant currency basis. Inflated copra prices (+113% YoY) and high base led to 814bps YoY decline in gross margins to 42.6%. EBIDTA margins declined by...

Marico (MRCO) reported a consolidated revenue growth of 31% YoY (in line) in 2QFY26. Domestic revenue growth was 35% YoY with volume growth of 7%.

With a 9% rise in domestic volumes (vs. the Street’s 8%) and a 20.1% EBITDA margin (vs. 20.3% est.), Marico posted good revenue but a weaker operating performance.

Sales +1% above consensus and our est., EBITDA +2% vs cons. and 1% above our est

MRCO delivered 22% revenue growth along with ~9% volume growth led by prices hikes taken in Parachute, robust growth in Foods and Premium Personal Care along with sustained recovery in VAHO. IBD continues to grow strong...

We maintain our long-term positive view on Marico with Jun-26E TP of Rs810 (on 50x P/E), given improved execution. However, the company’s near-term performance is likely to be impacted by the inflationary copra prices in both, India and Indonesia.

We retain a Buy rating on Marico with an unchanged PT of Rs. 825. The stock trades at 51x/44x its FY26E/FY27E EPS, respectively.

Marico’s Q4FY25 numbers were a mixed bag, led by sequential improvement in volume growth in the domestic business and revenue beating estimates, while OPM fell y-o-y and missed estimates.

The company reported robust revenue growth during the quarter on account of higher volume. However, margin and profitability were impacted by the higher cost of sales. Marico expects better outlook as its Food portfolio is expected to grow by 25% in FY26 owing to its scaling up of existing franchises and product innovations. Volume is expected to be better in FY26 as compared to FY25, indicating a favourable performance in the future. Its strong market share and new businesses...

Sales +3% above Bloomberg 4QFY25 consensus/our est. EBITDA was in line with cons. and 1% above our est

MRCO managed to deliver double-digit growth in FY25 led by Foods and Premium Personal Care revenue share increasing to ~22% in FY25 (11% in FY11) and double-digit INR sales growth in international business. Innovation funnel remains strong with portfolio diversification and scale up in Foods, D2C portfolio & B2C acquisitions. Beardo has ended FY25 with double-digit EBITDA margins whereas Plix has delivered low single digit EBITDA margin. MRCO plans to adopt the same strategy for scaling Digital-first franchises and targets double-digit margins by FY27. IBD is also focusing on improving mix by reducing...

We upgrade Marico to BUY from Add, and raise Mar-26E TP by ~16% to Rs810 (from Rs700), given FY25 management aspirations have been already realized and execution is continually improving.

Marico (MRCO) reported consol. revenue growth of 20% YoY (in line) in 4QFY25. Domestic revenue growth was 23% YoY, while volume growth was 7%. International growth was 11% YoY (16% CC growth).